Literature DB >> 20410781

Fetomaternal hemorrhage.

Blair J Wylie1, Mary E D'Alton.   

Abstract

Fetomaternal hemorrhage refers to the entry of fetal blood into the maternal circulation before or during delivery. Antenatal fetomaternal hemorrhage is a pathological condition with a wide spectrum of clinical variation. Secondary to the resultant anemia, fetomaternal hemorrhage may have devastating consequences for the fetus such as neurologic injury, stillbirth, or neonatal death. Presentation is frequently without an evident precipitating factor. Recognition may become apparent only after injury has occurred, if at all. The most common antenatal presentation is decreased fetal activity and a heightened index of suspicion is warranted in cases of persistent maternal perception of decreased fetal movements. The diagnostic standard, the Kleihauer-Betke screen, has several limitations. Management remains challenging. When detected antenatally, cordocentesis with intrauterine transfusion may be attempted to correct the anemia; however, repeat intrauterine transfusion or delivery may be necessitated to correct ongoing bleeding. Although the occurrence of large antenatal fetomaternal hemorrhage is fortunately rare, this entity likely remains underreported and underrecognized. A national registry should be created to advance our learning across institutions by reviewing the clinical presentations of fetomaternal hemorrhage, the variety of fetal heart rate tracings observed, the management strategies undertaken, and the outcomes achieved.

Entities:  

Mesh:

Year:  2010        PMID: 20410781     DOI: 10.1097/AOG.0b013e3181da7929

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  20 in total

1.  Experience in the evaluation of foeto-maternal haemorrhage by flow cytometry.

Authors:  Pier Luigi Tazzari; Francesca Ricci; Silvia Manfroi; Pasqualepaolo Pagliaro
Journal:  Blood Transfus       Date:  2012-10-10       Impact factor: 3.443

2.  Demographics, clinical characteristics and outcomes of neonates diagnosed with fetomaternal haemorrhage.

Authors:  Annemarie Stroustrup; Leonardo Trasande
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2012-02-28       Impact factor: 5.747

3.  Demographic and Behavioral Predictors of Severe Fetomaternal Hemorrhage: A Case-Control Study.

Authors:  Annemarie Stroustrup; Callie Plafkin; Thuy-An Tran; David A Savitz
Journal:  Neonatology       Date:  2016-02-10       Impact factor: 4.035

4.  The effect of adrenalectomy on the cardiac response to subacute fetal anemia.

Authors:  Sonnet S Jonker; Thomas D Scholz; Jeffrey L Segar
Journal:  Can J Physiol Pharmacol       Date:  2011-02       Impact factor: 2.273

5.  Impact of physician awareness on diagnosis of fetomaternal hemorrhage.

Authors:  Annemarie Stroustrup; Callie Plafkin; David A Savitz
Journal:  Neonatology       Date:  2014-02-08       Impact factor: 4.035

Review 6.  Chimerism in transfusion medicine: the grandmother effect revisited.

Authors:  Patricia A R Brunker
Journal:  Chimerism       Date:  2013-11-06

7.  The role of fetal inflammatory response syndrome and fetal anemia in nonpreventable term neonatal encephalopathy.

Authors:  J K Muraskas; A F Kelly; M S Nash; J R Goodman; J C Morrison
Journal:  J Perinatol       Date:  2016-01-21       Impact factor: 2.521

8.  Fetomaternal hemorrhage occurred in one fetus of dichorionic twin pregnancy.

Authors:  Kei Sagawa; Shunji Suzuki
Journal:  Clin Case Rep       Date:  2021-05-24

9.  Massive foeto-maternal transfusion: how long are foetal blood cells detectable in the maternal circulation?

Authors:  Fabrizio Signore; Laura Marchi; Nathalie Conti; Cinzia Orlandini; Annalisa Vidiri; Francesca Brugnolo; Franco Bambi; Simona Zaami; Giovanni Scambia; Anna F Cavaliere
Journal:  Blood Transfus       Date:  2021-05-21       Impact factor: 5.752

10.  Fetal-maternal hemorrhage: a case and literature review.

Authors:  Nino Solomonia; Karen Playforth; Eric W Reynolds
Journal:  AJP Rep       Date:  2011-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.